Why is Alkem Lab falling/rising?

As of 19-Aug, Alkem Laboratories Ltd is experiencing a price increase, currently at 5,393.50, with a change of 31.3, representing a rise of 0.58%. The stock has outperformed its sector by 0.71% today and has been on a consecutive gain for the last two days, accumulating a total return of 0.7% during this period. In terms of performance over various time frames, the stock has shown a 4.38% increase over the past week and a 7.84% increase over the past month, while it has underperformed year-to-date and over the past year with declines of 4.21% and 5.99%, respectively. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. However, there has been a significant drop in investor participation, with delivery volume falling by 67.91% compared to the 5-day average, which may raise concerns about liquidity despite the stock being liquid enough for trading. In the broader market context, Alkem Laboratories has outperformed the Sensex in the short term, with a 1-week return of 4.38% compared to the benchmark's 1.76%. Despite this positive short-term performance, the company faces challenges such as poor long-term growth, with net sales and operating profit growing at an annual rate of only 9.38% and 9.03% over the last five years. Additionally, there are signs of reducing promoter confidence, as they have decreased their stake by 2.09% in the previous quarter, which may signal concerns about the company's future prospects. While the company maintains a high return on equity and a low debt-to-equity ratio, these positive factors are somewhat overshadowed by the flat results reported in June and the lowest cash and cash equivalents recorded at Rs 1,563.08 crore.